Leukocyte Derived Microvesicles as Disease Progression Biomarkers in Slow Progressing Amyotrophic Lateral Sclerosis Patients
Daisy Sproviero(IFOM), Cristina Cereda(University of Milan), Michela Matteoli(Humanitas University), Sabrina La Salvia(University of Virginia), Orietta Pansarasa(Foundation Center), Susanna Zucca(Center for Genomic Science), Federico Colombo(IRCCS Humanitas Research Hospital), Andrea Malaspina(University College London), Marta Giannini(Vita-Salute San Raffaele University), Eliana Lauranzano(Humanitas University), Luca Lova, Mauro Ceroni(University of Pavia), Stella Gagliardi(University of Pavia), Luca Diamanti(Fondazione Istituto Neurologico Nazionale Casimiro Mondino), Alfredo Costa(University of Pavia)
Cited by 33
Related Papers
Characterization of human disease phenotypes associated with mutations in <i>TREX1</i>, <i>RNASEH2A</i>, <i>RNASEH2B</i>, <i>RNASEH2C</i>, <i>SAMHD1</i>, <i>ADAR</i>, and <i>IFIH1</i>
|American Journal of Medical Genetics Part A|2015|617
Astrocyte-Derived ATP Induces Vesicle Shedding and IL-1β Release from Microglia
|The Journal of Immunology|2005|597
Acid sphingomyelinase activity triggers microparticle release from glial cells
|The EMBO Journal|2009|589